Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen–glucose depletion

Authors:

Abstract
BACKGROUND AND PURPOSESeveral clinical trials andin vivoanimal experiments have suggested that blockade of angiotensin receptor type 1 (AT1) improves ischaemic outcomes. However, the mechanism(s) underlying these effects has not been elucidated. Here, we have investigated the protective effects of pretreatment with AT1receptor antagonists, losartan or telmisartan, against ischaemic insult to neuronsin vitro.EXPERIMENTAL APPROACHPrimary rat neuron–astrocyte co‐cultures and astrocyte‐defined medium (ADM)‐cultured pure astrocyte cultures were prepared. Ischaemic injury was modelled by oxygen–glucose depletion (OGD) and lactate dehydrogenase release after OGD was measured with or without AT1receptor antagonists or agonists (L162313), AT2receptor antagonist (PD123319) or agonist (CGP‐42112A) pretreatment, for 48 h. Activity of glutamate transporter 1 (GLT‐1) was evaluated by [3H]‐glutamate uptake assays, after AT1receptor agonists or antagonists. Immunoblot and real‐time PCR were used for analysis of protein and mRNA levels of GLT‐1.KEY RESULTSAT1receptor agonists augmented OGD‐induced cellular damage, which was attenuated by AT1receptor antagonists. AT1receptor antagonists also suppressed OGD‐induced extracellular glutamate release, reactive oxygen species production and nitric oxide generation. GLT‐1 expression and glutamate uptake activity were significantly enhanced by AT1receptor antagonists and impaired by AT1receptor agonists. AT1receptor stimulation suppressed both ADM‐induced GLT‐1 protein expression and mRNA levels. AT1b receptor knock‐down with siRNA enhanced GLT‐1 expression. In postnatal (P1–P21) rat brains, protein levels of GLT‐1 and AT1receptors were inversely correlated.CONCLUSIONS AND IMPLICATIONSSuppression of AT1receptor stimulation induced GLT‐1 up‐regulation, which ameliorated effects of ischaemic injury.

This publication has 58 references indexed in Scilit: